Hypertension: Biomarkers Clarify Heart Failure Risk - Report - MDSpire

Hypertension: Biomarkers Clarify Heart Failure Risk

  • By

  • Kathryn Wighton

  • February 23, 2026

  • 4 min

Share

Clinical Report: Hypertension and Heart Failure Risk in Prediabetes

Overview

Revise to clarify the fivefold increased heart failure risk and ensure it aligns with the source.

Background

Hypertension is a significant modifiable risk factor for heart failure (HF), and understanding its interaction with glycemic status and cardiac biomarkers is crucial for risk stratification. The identification of subclinical myocardial injury or stress through biomarkers can refine risk assessment in hypertensive patients, potentially guiding preventive strategies. This study highlights the importance of integrating glycemic status and biomarker data in managing patients with hypertension.

Data Highlights

GroupHF Risk (Fold Increase)
Prediabetes + Myocardial Injury4.20
Normoglycemia + Myocardial Injury3.28
Prediabetes + Myocardial Stress5.20
Normoglycemia + Myocardial Stress3.78

Key Findings

  • Adults with hypertension and prediabetes plus myocardial injury have a 4.20-fold higher risk of HF.
  • Prediabetes with myocardial stress is associated with a 5.20-fold higher risk of HF.
  • Prediabetes alone, without biomarker elevation, does not significantly increase HF risk.
  • Over a median follow-up of 3.2 years, 122 HF events were recorded among participants.
  • A 25% increase in hs-cTnI or NT-proBNP in prediabetic patients correlates with a 3.05-fold and 2.39-fold higher risk of HF, respectively.

Clinical Implications

Clinicians should consider both glycemic status and cardiac biomarkers when assessing heart failure risk in hypertensive patients. Early identification of those with prediabetes and elevated biomarkers may allow for targeted interventions to mitigate heart failure risk.

Conclusion

This study underscores the critical role of biomarkers in refining heart failure risk assessment among hypertensive patients with prediabetes, emphasizing the need for integrated clinical approaches in management.

References

  1. Kaze AD, Ballantyne CM, Berry JD, JAMA Cardiology, 2025 -- Hypertension, Prediabetes, and Heart Failure Risk
  2. conexiant — Risk Model Stratifies Heart Failure Outcomes
  3. Clinical Research in Cardiology — Integrating Clinical Assessment and Biomarkers to Forecast Diuretic Efficacy in Acute Heart Failure
  4. European Journal of Preventive Cardiology — Incorporating Ketone Bodies into a Multi-Biomarker Approach for Predicting Incident Heart Failure in a Diverse Atherosclerosis Cohort
  5. Clinical Research in Cardiology — A Review and Meta-Analysis of Randomized Trials on the Use of Implanted Hemodynamic Telemonitoring Devices for Heart Failure Management
  6. New High Blood Pressure Guideline Emphasizes Prevention, Early Treatment to Reduce CVD Risk - American College of Cardiology
  7. Prediabetes, Subclinical Myocardial Injury or Stress, and Heart Failure Risk for Adults With Hypertension | Cardiology | JAMA Cardiology | JAMA Network
  8. Predictive Value of Serum N-Terminal pro-B-Type Natriuretic Peptide and Troponin T for Incident Heart Failure: A Meta-Analysis of 9 International Cohorts - PubMed

Original Source(s)

Related Content